143B

143B

Cat.No.: CSC-C9149W

Species: Homo sapiens (Human)

Source: Bone

Morphology: mixed

  • Specification
  • Background
  • Scientific Data
  • Q & A
  • Customer Review
Cat.No.
CSC-C9149W
Description
This is a human osteosarcoma cell line, thymidine kinase negative (TK-)
Species
Homo sapiens (Human)
Source
Bone
Recommended Medium
EMEM and 10% h.i. FBS+0.015 mg/ml 5-bromo-2'-deoxyuridine
Morphology
mixed
Disease
Osteosarcoma
Storage and Shipping
liquid nitrogen vapor phase
Synonyms
143b; 143 B; 143B TK-; 143B.TK-; 143BTK-; 143TK-; HOS-143B; HOS-143b; GM05887; GM05887A
Citation Guidance
If you use this products in your scientific publication, it should be cited in the publication as: Creative Bioarray cat no. If your paper has been published, please click here to submit the PubMed ID of your paper to get a coupon.

The 143B cell line is a highly tumorigenic and metastatic human osteosarcoma line derived from the HOS (TE85, clone F-5) parental cells through stable transfection with an activated KRAS oncogene. Originally established from a 13-year-old female osteosarcoma patient, this KRAS-transformed derivative exhibits an aggressively malignant phenotype that faithfully models the lethal progression of osteosarcoma.

A defining advantage of 143B cells is their exceptional metastatic proclivity. When injected into immunocompromised mice—either orthotopically into the tibia or systemically via the left cardiac ventricle—they robustly generate osteolytic bone lesions and consistently colonize the lungs, thereby recapitulating the organotropism of clinical osteosarcoma. This spontaneous and experimental metastatic capacity makes the line a superior tool for dissecting the mechanisms of tumor cell dissemination, bone homing, and osteoclast-driven bone destruction. The cells can be readily engineered to stably express luciferase or fluorescent reporters, enabling sensitive, non-invasive bioluminescence imaging of primary tumor growth and micrometastatic burden over time.

Furthermore, 143B retains the intrinsic osteoblastic features of its origin, expressing bone-specific markers such as alkaline phosphatase and bone sialoprotein, and actively interacting with the bone microenvironment. Coupled with its rapid, reproducible in vitro growth and well-characterized genetic background, the 143B line offers an indispensable, highly reproducible preclinical platform for evaluating anti-metastatic therapies and bone-targeted agents in osteosarcoma.

Core Molecular Clock Factors Regulate Osteosarcoma Stem Cell Survival and Behavior via CSC/EMT Pathways and Lipid Droplet Biogenesis

The circadian clock, an intrinsic 24 h cellular timekeeping system, regulates fundamental biological processes, including tumor physiology and metabolism. Cancer stem cells (CSCs), a subpopulation of cancer cells with self-renewal and tumorigenic capacities, are implicated in tumor initiation, recurrence, and metastasis. Despite growing evidence for the circadian clock’s involvement in regulating CSC functions, its precise regulatory mechanisms remain largely unknown. Here, using a human osteosarcoma (OS) model (143B), we have shown that core molecular clock factors are critical for OS stem cell survival and behavior via direct modulation of CSC and lipid metabolic pathways.

In single-cell-derived spheroid formation assays, 143B OS cells exhibited robust spheroid-forming capacity under 3D culture conditions. Furthermore, siRNA-mediated depletion of core clock components (i.e.BMAL1CLOCKCRY1/2PER1/2) significantly reduced spheroid formation in 143B CSCs isolated from in vivo OS xenografts. We also found that knockdown of BMAL1, CLOCK, or CRY1/2 markedly impaired the migration and invasion capacities of 143B CSCs. At the molecular level, silencing of BMAL1, CLOCK, or CRY1/2 distinctly altered the expression of genes associated with stem cell properties and the epithelial–mesenchymal transition (EMT) in 143B CSCs. In addition, disruption of BMAL1CLOCK, or CRY1/2 expression significantly reduced lipid droplet formation by downregulating the expression of genes involved in lipogenesis (e.g.DGAT1FASNACSL4PKM2CHKASREBP1), which are closely linked to CSC/EMT processes. These findings highlight the critical role of the molecular circadian clock in regulating CSC properties and metabolism, underscoring the therapeutic potential of targeting the core clock machinery to enhance OS treatment outcomes.

Impact of Core Clock Gene Knockdown on 143B CSC Migration and Invasion.
Fig. 1. Knockdown of core clock genes reduces the migration and invasion capacities of 143B CSCs (Bhoumik, Sukanya, and Yool Lee. 2025).
Core Clock Genes Differentially Regulate the Expressions of CSC and EMT Markers.
Fig. 2. Knockdown of BMAL1 or CRY1/2 affects CSC/EMT gene expression in 143B CSCs (Bhoumik, Sukanya, and Yool Lee. 2025).

Ask a Question

Write your own review

  • You May Also Need

For research use only. Not for any other purpose.

Hot Products